2656. Eliciting Preferences for Zoster Vaccination in US Adults Aged 50 Years and Older

BACKGROUND: In October 2017, the Centers for Disease Control and Prevention (CDC) recommended the adjuvanted Recombinant Zoster Vaccine (RZV) for all adults aged ≥ 50 years, regardless of previous vaccination. Understanding patient preferences for herpes zoster (HZ) vaccination can inform providers,...

Descripción completa

Detalles Bibliográficos
Autores principales: Patterson, Brandon J, Meyers, Kelley, Stewart, Alexandra, Mange, Brennan, Hillson, Eric M, Cyr, Sonya, Poulos, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810089/
http://dx.doi.org/10.1093/ofid/ofz360.2334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810089/
http://dx.doi.org/10.1093/ofid/ofz360.2334

Ejemplares similares